US OptionsDetailed Quotes
AMED250117C85000
- 2.47
- -0.30-10.83%
15min DelayClose Dec 23 16:00 ET
2.47High2.47Low
2.47Open2.77Pre Close1 Volume1.01K Open Interest85.00Strike Price247.00Turnover33.80%IV2.82%PremiumJan 17, 2025Expiry Date0.07Intrinsic Value100Multiplier25DDays to Expiry2.40Extrinsic Value100Contract SizeAmericanOptions Type0.5347Delta0.0530Gamma27.01Leverage Ratio-0.0657Theta0.0288Rho14.44Eff Leverage0.0882Vega
Amedisys Stock Discussion
Sign in to post a comment
$Amedisys (AMED.US)$ divergency with good fundamental Also gap so it looks good and risk to rewards is acceptable
1
$Inhibikase Therapeutics (IKT.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
learn from
$Amedisys (AMED.US)$
$AMC Entertainment (AMC.US)$
$Fulcrum Therapeutics (FULC.US)$
JonesTrading analyst Soumit Roy initiates coverage on Inhibikase Therapeutics (NASDAQ:IKT) with a Buy rating and announces Price Target of $12.
$PharmaCyte Biotech (PMCB.US)$
2
No comment yet
Kofi : Do u see it going above 100 ?